Navigation Links
ResMed VPAP III ST-A

ProductsResMed VPAP III ST-A
Company ResMed Corp
Item ResMed VPAP III ST-A
Features 
  • Uses same device platform as the AutoSet SpiritTM, AutoSet RespondTM, and S7TM series of devices for lower inventory, training and labor costs
  • Available with optional integrated humidification
  • VsyncTM algorithm maintains reliable breath triggering and cycling performance to ensure that patients do not feel "out-of-sync with their VPAP, even when normal leaks occur
  • Monitors and compensates for leak
  • Automatically maintains reliable trigger and cycle thresholds
  • Includes adjustable trigger and cycle thresholdsa simple choice of "low, "medium, or "high.
  • IPAP MaxTM feature offers customizable maximum allowable inspiratory time to protect patients from prolonged inspiratory times
  • TiControl (Inspiratory Time Control) allows time limits to be set at either side of the patients ideal spontaneous inspiratory time to help prevent early or late cycling, as sometimes seen in patients with restrictive disorders
  • IPAP MinTM feature helps eliminate shortened inspiratory times often seen in restrictive patients, such as ALS and post-polio patients, and protects them from becoming under- ventilated and waking up gasping for air
  • Software-controlled, variable-speed motor technology and rise time settings provide more comfortable pressure and flow profiles for better treatment tolerance, resulting in improved patient comfort and compliance with less effort and fewer callbacks
  • Treatment effectiveness and usage data are available on the LCD and with download and viewing in AutoScanTM software
  • Range of alarms and modes Power Fail, Over Pressure, Over Use, Fault and Mask Off. Also features adjustable alarms, including Low Pressure, High Pressure and Low Minute Ventilation alarms
  • New non-vented circuit alarm alerts clinicians to non-vented mask connection issues
  • Choice of CPAP, Spontaneous, Spontaneous/Timed and Timed Treatment Modes
Description The VPAP III ST-A combines the exclusive features of the popular VPAP III series with adjustable trigger and cycle thresholds and a full range of clinician and patient-friendly alarms in a new, streamlined VPAP design. The VPAP III ST-A offers optional integrated humidification and comprehensive solutions for monitoring treatment effectiveness.
Info ResMed Corp
Customer Service: (800) 424-0737
Web site: http://www.resmed.com/

Related medicine products :

1. ResMed S8 Elite
2. ResMed S7 Elite CPAP
3. ResMed S7™ Lightweight CPAP Device
4. ResMed S8 Escape
5. ResMed AutoSet Spirit
6. ResMed AutoSet Respond
7. ResMed S8 AutoSet Vantage
8. ResMed VPAP III
9. ResMed VPAP III ST
...system from Del Mar Reynolds Medical. Available as...ergometer, PC, Cart, isolation transformer and a n...ct patient interface module that is used for resti... the CardioCollect as the patient interface module...
...diagnosis, the fully featured CH2000 Stress Test S...t measures T-wave alternans at the microvolt level...ol facility, this combines with the WAVESTAR ECG f... outstanding and noise-free ECG recordings with mi...
...ess system, the Quest, combines innovative touchsc...ilities. Combined with a 15" color monitor, users ... to program or select specific functions. Quest ev...ghting the step usually taken next. No more search...
...or makes refracting easier for you and your patien...rts in any order you wish, freeing you to conduct ...ng one button each time you want to move to the ne...random access gives you the option of performing a...
Medicine Products:
(Date:11/9/2009)...etary Vilsack, Governor Patrick, and Lieutenant Go...Newswire/ -- In a groundbreaking move for antihung...r) called for all of the state,s hospitals to take...r care. ,, "With 554,000 people in Massachuset...ess conference at UMass Memorial Health Care in Wo...
(Date:11/9/2009)...PRNewswire-Asia-FirstCall/ -- Mindray Medical,Inte...r, manufacturer and,marketer of medical devices wo...nancial results for the third quarter and nine mon...or Operations as of September 30, 2009, -- Thir...n increase of, 3.1% over the third quarter o...
(Date:11/9/2009)...guage, Federal Trade Commission Involvement Need t... Inclusion of a provisi...H.R. 3962) allowing insurance agents to sell healt...s positive, but other issues remain to be addresse...tion of Professional Insurance Agents (PIA). ,,...
(Date:11/9/2009)...re/ -- Tracy Anderson, trainer to Gwyneth Paltrow,...sting two events at her LA studio this week that a...waited Nutritional Meal Plan and Delivery Service,...e and Lifestyle Menu. She will also be teaching a...of cardio and muscle structure work. Both events ...
(Date:11/9/2009)...equally, study finds, , , MONDAY, Nov. ...ing drug Plavix (clopidogrel) works about the same... trials has found. , "After this study, I can s...men with this very important drug," said Dr. Jeffr...s at New York University Langone Medical Center in...
Breaking Medicine News(10 mins):Health News:McGovern and Project Bread Launch Hospital Hunger Initiative 2Health News:McGovern and Project Bread Launch Hospital Hunger Initiative 3Health News:Mindray Announces Third Quarter 2009 Financial Results 2Health News:Mindray Announces Third Quarter 2009 Financial Results 3Health News:Mindray Announces Third Quarter 2009 Financial Results 4Health News:Mindray Announces Third Quarter 2009 Financial Results 5Health News:Mindray Announces Third Quarter 2009 Financial Results 6Health News:Mindray Announces Third Quarter 2009 Financial Results 7Health News:Mindray Announces Third Quarter 2009 Financial Results 8Health News:Mindray Announces Third Quarter 2009 Financial Results 9Health News:Mindray Announces Third Quarter 2009 Financial Results 10Health News:Mindray Announces Third Quarter 2009 Financial Results 11Health News:Mindray Announces Third Quarter 2009 Financial Results 12Health News:Mindray Announces Third Quarter 2009 Financial Results 13Health News:Mindray Announces Third Quarter 2009 Financial Results 14Health News:Mindray Announces Third Quarter 2009 Financial Results 15Health News:Mindray Announces Third Quarter 2009 Financial Results 16Health News:Mindray Announces Third Quarter 2009 Financial Results 17Health News:Mindray Announces Third Quarter 2009 Financial Results 18Health News:PIA Says Inclusion of Agents in House Healthcare Bill is Positive, But Concerns Remain 2Health News:PIA Says Inclusion of Agents in House Healthcare Bill is Positive, But Concerns Remain 3Health News:Celebrity Trainer Tracy Anderson Sharing Her Fitness and Diet Secrets This Week 2Health News:No Gender Gap Found for Clot-Busting Drug 2Health News:No Gender Gap Found for Clot-Busting Drug 3
... with post traumatic stress disorder (PTSD) have s...f life according to research by Dr. J. Donald Rich...s co-investigators. , The research, published thi...ies just as much to peacekeeping veterans as to co...
...ast-Growth Companies to Quell Your Recession Fears... Nuclear Medicine Professionals, Inc. Ranks No. 46... 1161 on the Inc. 5000 With Three-Year Sales Growt...c.] on its annual ranking of the 5000 fastest-grow...
...Is Needed, Says Editor of "The Oncologist", DURHA...,a study supporting the use of computed tomography...in smokers and other people at risk, the,Editor-in... ), " ... the results of this key lung cancer pr...
... 1, 2008 is a landmark,day in Tennessee history. T...erm Care Partnership that rewards Tennesseans for ...y. By encouraging the purchase of long-term,care i...te Medicaid budget saves money., Tennessee joins ...
..., Inc.,(Nasdaq: THRM ), a leader in non-invasive ... announced that it will present at the 2008 Maxim ...n is scheduled for 10:00 a.m.,Eastern Time on Tues...inancial results., Attendance at the conference i...
... - Share Exchange Offer to the Holders of the Foll... ISIN: US4781601046 - Symbol: JNJ, The K&N Value ...ities,named above for every 1 Johnson & Johnson sh...th November,2008., K&N Value Select Corp. reserve...
Other Medicine News:Health News:Whether combat or peacekeeping, PTSD impacts veterans' well-being 2Health News:America's 5000 Fastest-Growing Private Companies Revealed 2Health News:New Questions Raised About Lung Cancer Screening 2Health News:New Questions Raised About Lung Cancer Screening 3Health News:Tennessee Introduces Long-Term Care Partnership Insurance Policies and Producer Training Requirement 2
(Date:11/9/2009)...9 Hologic, Inc. (Hologic...oper, manufacturer and supplier of premium diagnos...s dedicated to serving the healthcare needs of wom...rter and fiscal year ended September 26, 2009. In ...ectors has promoted Robert Cascella to Chief Execu...
(Date:11/9/2009)..., N.J., Nov. 9 Pharmasse... present at the Sixth Annual Lazard Capital Market...ld at the St Regis Hotel in New York City (Novembe... President and Chief Executive Officer, will provi...er 18, 2009 at 3:45 PM (ET). ,, To access a sim...
(Date:11/9/2009)...09 Arena Pharmaceuticals...esults for the third quarter ended September 30, 2...le to common stockholders in the third quarter of ...d to a net loss allocable to common stockholders i...0.76 per share, and a net loss allocable to common...
Breaking Medicine Technology:Hologic Announces Fourth Quarter and Fiscal 2009 Operating Results 2Hologic Announces Fourth Quarter and Fiscal 2009 Operating Results 3Hologic Announces Fourth Quarter and Fiscal 2009 Operating Results 4Hologic Announces Fourth Quarter and Fiscal 2009 Operating Results 5Hologic Announces Fourth Quarter and Fiscal 2009 Operating Results 6Hologic Announces Fourth Quarter and Fiscal 2009 Operating Results 7Hologic Announces Fourth Quarter and Fiscal 2009 Operating Results 8Hologic Announces Fourth Quarter and Fiscal 2009 Operating Results 9Hologic Announces Fourth Quarter and Fiscal 2009 Operating Results 10Hologic Announces Fourth Quarter and Fiscal 2009 Operating Results 11Hologic Announces Fourth Quarter and Fiscal 2009 Operating Results 12Hologic Announces Fourth Quarter and Fiscal 2009 Operating Results 13Hologic Announces Fourth Quarter and Fiscal 2009 Operating Results 14Hologic Announces Fourth Quarter and Fiscal 2009 Operating Results 15Hologic Announces Fourth Quarter and Fiscal 2009 Operating Results 16Hologic Announces Fourth Quarter and Fiscal 2009 Operating Results 17Hologic Announces Fourth Quarter and Fiscal 2009 Operating Results 18Hologic Announces Fourth Quarter and Fiscal 2009 Operating Results 19Hologic Announces Fourth Quarter and Fiscal 2009 Operating Results 20Hologic Announces Fourth Quarter and Fiscal 2009 Operating Results 21Hologic Announces Fourth Quarter and Fiscal 2009 Operating Results 22Hologic Announces Fourth Quarter and Fiscal 2009 Operating Results 23Hologic Announces Fourth Quarter and Fiscal 2009 Operating Results 24Hologic Announces Fourth Quarter and Fiscal 2009 Operating Results 25Hologic Announces Fourth Quarter and Fiscal 2009 Operating Results 26Hologic Announces Fourth Quarter and Fiscal 2009 Operating Results 27Hologic Announces Fourth Quarter and Fiscal 2009 Operating Results 28Pharmasset to Present at Lazard Capital Markets Healthcare Conference 2Pharmasset to Present at Lazard Capital Markets Healthcare Conference 3Arena Pharmaceuticals Announces Third Quarter 2009 Financial Results and Recent Developments 2Arena Pharmaceuticals Announces Third Quarter 2009 Financial Results and Recent Developments 3Arena Pharmaceuticals Announces Third Quarter 2009 Financial Results and Recent Developments 4Arena Pharmaceuticals Announces Third Quarter 2009 Financial Results and Recent Developments 5Arena Pharmaceuticals Announces Third Quarter 2009 Financial Results and Recent Developments 6Arena Pharmaceuticals Announces Third Quarter 2009 Financial Results and Recent Developments 7FDA Approves Boston Scientifics TAXUS 28R 29 Liberte 28R 29 Long Stent 51900 1FDA Approves Boston Scientifics TAXUS 28R 29 Liberte 28R 29 Long Stent 51900 2FDA Approves Boston Scientifics TAXUS 28R 29 Liberte 28R 29 Long Stent 51900 3FDA Approves Boston Scientifics TAXUS 28R 29 Liberte 28R 29 Long Stent 51900 4PAL Health Technologies Wins State Level Prestigious Employer of the Year Award 51895 1PAL Health Technologies Wins State Level Prestigious Employer of the Year Award 51895 2Sunitinib Benefit Explored in Poor Prognosis Kidney Cancer 51892 1Sunitinib Benefit Explored in Poor Prognosis Kidney Cancer 51892 2